Search Results 1141-1150 of 18753 for autoimmune hepatitis

1. End-stage renal disease - Doctors and departments - Mayo Clinic

   Kidney disease and chronic liver disease; Genetics behind kidney diseases; Understanding what underlies autosomal dominant polycystic kidney disease and ...

2. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

   * Onset of autoimmune encephalitis (AIE) symptoms \<=9 months before randomization * ... * Positive hepatitis B (HBV) and hepatitis C (HCV) test at screening * ...

3. International and National Data and Sample Registry - Hepatobiliary Cancer Laboratory - Mayo Clinic Research

   ... hepatitis C virus infection to hepatocellular carcinoma, and clinical outcomes of patients with hepatocellular carcinoma by using a high-density single ...

4. Overview - RNA Nanotherapeutics: Tushar C. Patel

   Patel is working to identify new target molecules and mechanisms for liver disease and cancers through the study and use of extracellular vesicles, noncoding ...

5. Biotherapeutics - 2021 Archives - Mayo Clinic News Network

   Science Saturday: Regenerative technology uncovers new discoveries in liver disease. Susan Buckles. November 20, 2021. Mayo Clinic Symposium on Regenerative ...

6. Valerian: A safe and effective herbal sleep aid? - Mayo Clinic

   If you have liver disease, avoid taking valerian. And because valerian can make you drowsy, avoid driving or operating dangerous machinery after taking it ...

7. Core Consultative Hematology Group - Overview - Mayo Clinic

   Anemia and red cell disorders; Autoimmune hemolytic anemias; Autoimmune thrombocytopenia; Blood transfusion; Hemoglobinopathies; Hemolytic uremic syndrome ...

8. A Study to Evaluate the Effectiveness and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR) - Mayo Clinic

   ... liver disease (fibrosis stages 2-3 who are overweight or obese and have ... Model for End-Stage Liver Disease (MELD) score > 12. Prior history or ...

9. MRD Guided, Fixed Duration Therapy With Loxo-305 and Venetoclax for Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   excluded. - Hepatitis C virus (HCV): If hepatitis C antibody result is positive, patient will need to have a negative result for hepatitis C ribonucleic acid ( ...

10. Second-line treatment options for hepatocellular carcinoma - Mayo Clinic

    HCC , the most common type of primary liver cancer, occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or ...